garcinol and Angiogenesis, Pathologic

garcinol has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aggarwal, S; Das, SN1
Najafi, R; Pourjafar, M; Ranjbarnejad, T; Saidijam, M; Tafakh, MS; Talebzadeh, F1

Other Studies

2 other study(ies) available for garcinol and Angiogenesis, Pathologic

ArticleYear
Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:6

    Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Mouth Neoplasms; Neovascularization, Pathologic; NF-kappa B; Plant Extracts; Terpenes; Tumor Cells, Cultured

2016
Garcinol exhibits anti-proliferative activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells.
    Human & experimental toxicology, 2017, Volume: 36, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Dinoprostone; Gene Expression Regulation; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microsomes; Neovascularization, Pathologic; Prostaglandin-E Synthases; Receptors, CXCR4; Signal Transduction; Terpenes; Vascular Endothelial Growth Factor A

2017